{"id":"W4386277771","doi":"10.1016/s2152-2650(23)01412-x","title":"MM-164 First Results From the RedirecTT-1 Study With Teclistamab (Tec) + Talquetamab (Tal) Simultaneously Targeting BCMA and GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Health Services; McGill University; McGill University Health Centre","funders":"lékařská fakulta Univerzity Karlovy; University of California, San Francisco; Erasmus Universitair Medisch Centrum Rotterdam; Université de Toulouse; Centre Hospitalier Universitaire de Toulouse; Ankara Universitesi; Univerzita Karlova v Praze; Department of Medicine, University of California, San Francisco; Sanofi","keywords":"Multiple myeloma; TEC; Medicine; Oncology; Internal medicine; Refractory (planetary science); Biology; Geology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00173049,0.001054594,0.002691161,0.0003623924,0.0004364923,0.001487005,0.0005947857,0.001241591,0.002917003],"category_scores_gemma":[0.001143896,0.0004508125,0.002877765,0.0003540679,0.0004984178,0.0006927546,0.0004038947,0.003104153,0.001111014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001337508,"about_ca_system_score_gemma":0.0009537511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001010559,"about_ca_topic_score_gemma":0.002451933,"domain_scores_codex":[0.999392,0.0002527513,0.00004604431,0.00009569187,0.00008305992,0.0001305223],"domain_scores_gemma":[0.9992794,0.000152798,0.0001314735,0.00009817427,0.00006267862,0.0002753951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6964614,0.01856675,0.03047439,0.001381773,0.008833945,0.0006493172,0.0003763822,0.001997709,0.05047349,0.0005539738,0.009154816,0.181076],"study_design_scores_gemma":[0.3589799,0.4598123,0.122468,0.0002554748,0.0120888,0.001223434,0.000189374,0.001453974,0.01716343,0.0006963895,0.02552516,0.0001437472],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976202,0.01145617,0.0008416818,0.001493619,0.0004028429,0.0008217226,0.003304567,0.0001632166,0.005314185],"genre_scores_gemma":[0.9843845,0.002599691,0.001131808,0.002196093,0.0003940238,0.0005103406,0.00506802,0.00006587864,0.003649583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002917003,"threshold_uncertainty_score":0.009758294,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0233008736586251,"score_gpt":0.2885946003179734,"score_spread":0.2652937266593483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}